There has been a lot of confusion on diabetes social media about the recent Medicare announcement on Dexcom and smartphones: exactly what it means and when the new policy will be implemented. The confusion was magnified by some incorrect information in the Dexcom press release and a wrong statement in the recent Diatribe article. I shared a little info here a couple of days ago. Some of you may know that I am a blogger and I finally decided that I needed to do my homework and find out what the real story is. I think that if you are affected by this issue that this blogpost will clarify the status of the policy change.
If you do not know who Christel Marchand Aprigliano is, she is the face of the diabetes advocacy organization DPAC. She attended the June 13 meeting with CMS in Washington, DC along with representatives from AACE, the National Association of the Blind, the Endocrine Society, the Pediatric Endo Society, and the Diabetes Advocacy Alliance. She is also the founder of the Diabetes UnConference. She has also attended meetings with both Dexcom and Tandem. She is an extremely reliable source and is quoted extensively in my blogpost. She shared my blogpost on Facebook and vouched for its accuracy.